What is the treatment for ocular rosacea using doxycycline (antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Doxycycline is an effective treatment for ophthalmic rosacea, and the recommended dose is 40 mg once daily, which utilizes the drug's anti-inflammatory properties at a dose below that which can typically kill bacteria. This dose has been shown to be as effective as 100 mg once daily for moderate-to-severe rosacea 1. The treatment should be allowed sufficient time to take effect, typically 6-12 weeks, before considering it a failure and choosing another option 1.

Some key points to consider when treating ophthalmic rosacea with doxycycline include:

  • Take doxycycline with a full glass of water, either 1 hour before or 2 hours after meals, and avoid taking it before lying down
  • Common side effects include photosensitivity, gastrointestinal upset, and yeast infections
  • Doxycycline works by reducing inflammation and decreasing bacterial lipases that contribute to meibomian gland dysfunction
  • While treating with doxycycline, maintain good eyelid hygiene with warm compresses and gentle lid cleansing, use preservative-free artificial tears for dryness, and continue any prescribed topical treatments
  • Improvement typically begins within 2-4 weeks, but complete resolution may take several months
  • Avoid doxycycline if pregnant, breastfeeding, or in children under 8 years old due to potential tooth discoloration and bone growth effects

It's also important to note that doxycycline 40 mg has been shown to be superior to placebo and noninferior to doxycycline 100 mg in the treatment of rosacea 1. Additionally, the long-term efficacy and safety of modified-release doxycycline as monotherapy has been demonstrated in a two-part study, which showed that once-daily doxycycline maintenance therapy enhanced long-term rosacea control 1.

From the Research

Treatment of Ophthalmic Rosacea with Doxycycline

  • Ophthalmic rosacea can be treated with doxycycline, which is usually administered at a dose of 40-100 mg daily for 3-6 months 2.
  • A sub-antimicrobial dose of slow release doxycycline 40 mg daily is an effective long-term therapy for ocular rosacea, with no associated side effects of long-term antibiotic therapy or risk of resistance 3.
  • The treatment of ocular rosacea with once-daily low-dose doxycycline has been shown to be effective, with significant improvement in symptoms and clinical findings after 12 weeks of treatment 4.

Dosage and Administration

  • The recommended dose of doxycycline for the treatment of ophthalmic rosacea is 40 mg daily, administered in a slow-release form 3, 4.
  • The treatment duration can vary, but it is typically administered for at least 2-3 months, with some studies showing efficacy after 12 weeks of treatment 3, 4.

Efficacy and Safety

  • Studies have shown that doxycycline is effective in reducing the symptoms of ophthalmic rosacea, including blepharitis, conjunctival redness, and corneal ulcerations 3, 4.
  • The use of sub-antimicrobial dose doxycycline has been shown to be safe, with minimal side effects and no increased risk of antibiotic resistance 3, 5.
  • However, doxycycline is contraindicated in pregnant or nursing women, and in infants and children due to the risk of permanent teeth discoloration and decreased bone growth rate 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Systemic therapy of rosacea].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013

Research

Treatment of ocular rosacea with 40 mg doxycycline in a slow release form.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2011

Research

Update on rosacea and anti-inflammatory-dose doxycycline.

Drugs of today (Barcelona, Spain : 1998), 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.